Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Hemispherx_Biopharma> ?p ?o }
Showing triples 1 to 37 of
37
with 100 triples per page.
- Hemispherx_Biopharma abstract "Hemispherx Biopharma (NYSE MKT: HEB) is a biopharmaceutical company based in Philadelphia, Pennsylvania. Founded in 1990, the company has 32 employees.The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for chronic fatigue syndrome.On April 3, 2001, Hemispherx Biopharma, Inc. adjusted and restated its 1999 financial statements to reflect a charge relating to an extension of the exercise period to certain warrants as of February 1999. On April 3, 2006, Hemispherx Biopharma, Inc. restated financial results for 2003 and 2004 due to accounting mistakes related to debentures and warrants issued between March 2003 and August 2005.".
- Hemispherx_Biopharma wikiPageExternalLink www.hemispherx.net.
- Hemispherx_Biopharma wikiPageID "9519252".
- Hemispherx_Biopharma wikiPageLength "2460".
- Hemispherx_Biopharma wikiPageOutDegree "12".
- Hemispherx_Biopharma wikiPageRevisionID "705839075".
- Hemispherx_Biopharma wikiPageWikiLink Biopharmaceutical.
- Hemispherx_Biopharma wikiPageWikiLink Category:Biopharmaceutical_companies.
- Hemispherx_Biopharma wikiPageWikiLink Category:Companies_based_in_Philadelphia,_Pennsylvania.
- Hemispherx_Biopharma wikiPageWikiLink Category:Companies_listed_on_NYSE_MKT.
- Hemispherx_Biopharma wikiPageWikiLink Category:Pharmaceutical_companies_established_in_1990.
- Hemispherx_Biopharma wikiPageWikiLink Chronic_fatigue_syndrome.
- Hemispherx_Biopharma wikiPageWikiLink Drug.
- Hemispherx_Biopharma wikiPageWikiLink Immunotherapy.
- Hemispherx_Biopharma wikiPageWikiLink Pennsylvania.
- Hemispherx_Biopharma wikiPageWikiLink Philadelphia.
- Hemispherx_Biopharma wikiPageWikiLink RNA.
- Hemispherx_Biopharma wikiPageWikiLink Rintatolimod.
- Hemispherx_Biopharma wikiPageWikiLinkText "Hemispherx Biopharma".
- Hemispherx_Biopharma wikiPageUsesTemplate Template:AMEX.
- Hemispherx_Biopharma wikiPageUsesTemplate Template:Reflist.
- Hemispherx_Biopharma subject Category:Biopharmaceutical_companies.
- Hemispherx_Biopharma subject Category:Companies_based_in_Philadelphia,_Pennsylvania.
- Hemispherx_Biopharma subject Category:Companies_listed_on_NYSE_MKT.
- Hemispherx_Biopharma subject Category:Pharmaceutical_companies_established_in_1990.
- Hemispherx_Biopharma hypernym Company.
- Hemispherx_Biopharma type Company.
- Hemispherx_Biopharma type Company.
- Hemispherx_Biopharma type Establishment.
- Hemispherx_Biopharma comment "Hemispherx Biopharma (NYSE MKT: HEB) is a biopharmaceutical company based in Philadelphia, Pennsylvania. Founded in 1990, the company has 32 employees.The company has created an immunomodulatory double stranded RNA drug called Ampligen. The company is developing Ampligen to use as a treatment for chronic fatigue syndrome.On April 3, 2001, Hemispherx Biopharma, Inc.".
- Hemispherx_Biopharma label "Hemispherx Biopharma".
- Hemispherx_Biopharma sameAs Q5712100.
- Hemispherx_Biopharma sameAs m.03p2b0n.
- Hemispherx_Biopharma sameAs Q5712100.
- Hemispherx_Biopharma wasDerivedFrom Hemispherx_Biopharma?oldid=705839075.
- Hemispherx_Biopharma homepage www.hemispherx.net.
- Hemispherx_Biopharma isPrimaryTopicOf Hemispherx_Biopharma.